When the current federal administration took office, it issued a memorandum requiring, among other things, that federal agencies delay the issuance ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one oral ...

non-engineered TIL using NSCLC tumor samples. The poster for abstract LB359 provides evidence that, as observed with melanoma 2, the OBX-115 process generates a minimally exhausted, CD8+ enriched ...

Abstract and poster presentation details are below: Title: “Phase 1 dose escalation results of the WEE1 inhibitor, azenosertib, in combination with encorafenib and cetuximab in patients with ...

LOS ALTOS, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the ...

Perosphere CEO Dr. Sasha Bakhru will deliver an oral presentation highlighting the ... to DOAC-induced anticoagulation in whole blood samples from DOAC patients at peak anticoagulation and at ...

Effective communication is an important part of... The verbal presentation example is another time-honored aspect of running a business. Presentations are very common in companies that sell ...

The poster is scheduled for presentation on June 3, 2024, from 1:30pm to 4:30pm CST. “We are proud to accept ASCO’s invitation to present at its 2024 Annual Meeting, the most significant ...